Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 506-511

  Lee, Danbi ^a   Bae, Jinbum ^a   Kim, Yoon Kyu ^a   Gil, Minchan ^a,b   Lee, Joo Yong ^a,b   Park, Chan Sik ^b   Lee, Kyung Jin ^a,b  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Berberine; Heme oxygenase 1; High mobility group box 1; Inflammation; Macrophage; Nitric oxide synthase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BERBERINE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTOPORPHYRIN ZINC; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BERBERINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEME OXYGENASE-1; HMGB1 PROTEIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84873702591     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.143     Document Type: Article

References (34)

1. Aziz M., Jacob A., Yang W.L., Matsuda A., Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J. Leukoc. Biol. 2012.
2. Huang W., Tang Y., Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010, 51:119-126.
3. Thomas J.O., Stott K. H1 and HMGB1: modulators of chromatin structure. Biochem. Soc. Trans. 2012, 40:341-346.
4. Srisook K., Kim C., Cha Y.N. Molecular mechanisms involved in enhancing HO-1 expression: de-repression by heme and activation by Nrf2, the " one-two" punch. Antioxid. Redox Signal. 2005, 7:1674-1687.
5. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
6. Sama A.E., D'Amore J., Ward M.F., Chen G., Wang H. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad. Emerg. Med. 2004, 11:867-873.
7. Jang H.J., Kim Y.M., Tsoyi K., Park E.J., Lee Y.S., Kim H.J., Lee J.H., Joe Y., Chung H.T., Chang K.C. Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in RAW 264.7 cells and improves survival in septic animals. Antioxid. Redox Signal. 2012, 17:878-889.
8. Tsoyi K., Lee T.Y., Lee Y.S., Kim H.J., Seo H.G., Lee J.H., Chang K.C. Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo. Mol. Pharm. 2009, 76:173-182.
9. Wu M.L., Ho Y.C., Lin C.Y., Yet S.F. Heme oxygenase-1 in inflammation and cardiovascular disease. Am. J. Cardiovasc. Dis. 2011, 1:150-158.
10. Surh Y.J., Kundu J.K., Li M.H., Na H.K., Cha Y.N. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch. Pharm. Res. 2009, 32:1163-1176.
11. Martin D., Rojo A.I., Salinas M., Diaz R., Gallardo G., Alam J., De Galarreta C.M., Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 2004, 279:8919-8929.
12. Farombi E.O., Surh Y.J. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J. Biochem. Mol. Biol. 2006, 39:479-491.
13. Luz N.F., Andrade B.B., Feijo D.F., Araujo-Santos T., Carvalho G.Q., Andrade D., Abanades D.R., Melo E.V., Silva A.M., Brodskyn C.I., Barral-Netto M., Barral A., Soares R.P., Almeida R.P., Bozza M.T., Borges V.M. Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. J. Immunol. 2012, 188:4460-4467.
14. Bonelli M., Savitskaya A., Steiner C.W., Rath E., Bilban M., Wagner O., Bach F.H., Smolen J.S., Scheinecker C. Heme oxygenase-1 end-products carbon monoxide and biliverdin ameliorate murine collagen induced arthritis. Clin. Exp. Rheumatol. 2012, 30:73-78.
15. Imanshahidi M., Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008, 22:999-1012.
16. Tong N., Zhang J., Chen Y., Li Z., Luo Y., Zuo H., Zhao X. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol. Lett. 2012, 3:1263-1267.
17. Tan W., Li Y., Chen M., Wang Y. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int. J. Nanomedicine 2011, 6:1773-1777.
18. Lau C.W., Yao X.Q., Chen Z.Y., Ko W.H., Huang Y. Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 2001, 19:234-244.
19. Boberek J.M., Stach J., Good L. Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS ONE 2010, 5:e13745.
20. Yin J., Zhang H., Ye J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr. Metab. Immune Disord. Drug Targets 2008, 8:99-111.
21. Hsu Y.Y., Chen C.S., Wu S.N., Jong Y.J., Lo Y.C. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells. Eur. J. Pharm. Sci. 2012, 46:415-425.
22. Kim J.Y., Jung K.S., Lee K.J., Na H.K., Chun H.K., Kho Y.H., Jeong H.G. The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages. Cancer Lett. 2004, 213:147-154.
23. Johnson M.R., Wang K., Smith J.B., Heslin M.J., Diasio R.B. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal. Biochem. 2000, 278:175-184.
24. Chen J.H., Huang S.M., Tan T.W., Lin H.Y., Chen P.Y., Yeh W.L., Chou S.C., Tsai C.F., Wei I.H., Lu D.Y. Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. Int. Immunopharmacol. 2012, 12:94-100.
25. Alam J., Cook J.L. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr. Pharm. Des. 2003, 9:2499-2511.
26. Manoharan S., Sindhu G., Nirmal M.R., Vetrichelvi V., Balakrishnan S. Protective effect of berberine on expression pattern of apoptotic, cell proliferative, inflammatory and angiogenic markers during 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. Pak. J. Biol. Sci. 2011, 14:918-932.
27. Lu D.Y., Tang C.H., Chen Y.H., Wei I.H. Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J. Cell. Biochem. 2010, 110:697-705.
28. Chavan S.S., Huerta P.T., Robbiati S., Valdes-Ferrer S.I., Ochani M., Dancho M., Frankfurt M., Volpe B.T., Tracey K.J., Diamond B. Response to " HMGB1 mediates cognitive impairment in sepsis survivors" . Mol. Med. 2012, 18:1359.
29. Alam J., Cook J.L. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am. J. Respir. Cell Mol. Biol. 2007, 36:166-174.
30. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
31. Lahti A., Sareila O., Kankaanranta H., Moilanen E. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression. BMC Pharmacol. 2006, 6:5.
32. Lavrovsky Y., Schwartzman M.L., Levere R.D., Kappas A., Abraham N.G. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. USA 1994, 91:5987-5991.
33. Zhang X., Lu L., Dixon C., Wilmer W., Song H., Chen X., Rovin B.H. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. Kidney Int. 2004, 65:798-810.
34. Hwang Y.P., Jeong H.G. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol. Appl. Pharmacol. 2010, 242:18-28.